Related Experiment Video

Updated: Aug 9, 2026

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
10:21

Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function

Published on: August 8, 2019

[Rheographic (semiquantitative) hepatic flow measurements with infinite time constant as compared with the

G C Garbini, G Civiero, L L Barbieri

    Bollettino Della Societa Italiana Di Cardiologia
    |January 1, 1970
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Human Fetal Blood Flow Quantification with Magnetic Resonance Imaging and Motion Compensation06:56

    Human Fetal Blood Flow Quantification with Magnetic Resonance Imaging and Motion Compensation

    Published on: January 7, 2021

    Imaging and Quantification of the Hepatic Vasculature of Mice Using Ultrafast Doppler Ultrasound07:03

    Imaging and Quantification of the Hepatic Vasculature of Mice Using Ultrafast Doppler Ultrasound

    Published on: July 19, 2024

    Related Concept Videos

    Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

    Imaging Studies II: Positron Emission Tomography and Scintigraphy

    Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
    Fundamental Principles of PET
    One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

    One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

    This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
    On...